CAPPED BONUSZERTIFIKAT - STRYKER CORP. Stock

Certificat

DE000PC5RUC5

Market Closed - Boerse Frankfurt Warrants 03:40:10 2024-05-10 pm EDT
270.8 EUR +0.09% Intraday chart for CAPPED BONUSZERTIFIKAT - STRYKER CORP.
Current month-0.38%
1 month-0.59%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
24-05-10 270.8 +0.08% 0
24-05-09 270.6 +0.06% 0
24-05-08 270.4 -0.41% 0
24-05-07 271.5 +0.84% 0
24-05-06 269.2 +0.12% 0

Real-time Boerse Frankfurt Warrants

Last update May 10, 2024 at 03:40 pm EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5RUC
ISINDE000PC5RUC5
Date issued 2024-02-27
Strike 340 $
Maturity 2025-12-19 (586 Days)
Parity 1 : 1
Emission price 266.3
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 274.8
Lowest since issue 265.7
Spread 0.5
Spread %0.18%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW